EICHOR
● Completed
Veterans Coordinated Community Care (3C) Study
Condition: Suicide · Sponsor: Brown University
About this study
Veterans Coordinated Community Care (3C) Study will recruit 850 Veterans at risk for suicide post inpatient hospitalization. Each participant will be randomly assigned to treatment as usual (TAU) or TAU plus the Coping Long Term with Active Suicide Program (CLASP), with follow-up for 6 months after discharge. Outcomes include suicide-related behaviors (including deaths due to suicide, opioid overdose, or other substance-related accidents; and nonfatal suicide attempts) and suicidal ideation and functioning.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (7)
| Central Arkansas Veterans Healthcare System | Little Rock, Arkansas, United States | — |
| VA Boston Healthcare System | Boston, Massachusetts, United States | — |
| Minneapolis VA Health Care System | Minneapolis, Minnesota, United States | — |
| VA St. Louis Health Care System | St Louis, Missouri, United States | — |
| VA Pittsburgh Healthcare System | Pittsburgh, Pennsylvania, United States | — |
| VA Tennessee Valley Health Care System | Murfreesboro, Tennessee, United States | — |
| VA North Texas Healthcare System | Dallas, Texas, United States | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05272176